CliffBio
small molecule

MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER

MILRINONE LACTATE

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameMILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Active ingredientMILRINONE LACTATE
StrengthEQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalMay 2002
Marketing statusRX

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.